Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for LifeMD (LFMDP) over the last 14 years, with Q3 2025 value amounting to $4.6 million.

  • LifeMD's Change in Accured Expenses fell 2484.07% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$319253.0, marking a year-over-year decrease of 10478.31%. This contributed to the annual value of $8.0 million for FY2024, which is 7140.69% up from last year.
  • LifeMD's Change in Accured Expenses amounted to $4.6 million in Q3 2025, which was down 2484.07% from -$3.1 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Change in Accured Expenses peaked at $6.2 million during Q3 2024, and registered a low of -$3.1 million during Q2 2025.
  • Its 5-year average for Change in Accured Expenses is $1.0 million, with a median of $771146.0 in 2021.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first surged by 134026.49% in 2023, then crashed by 165947.4% in 2025.
  • Over the past 5 years, LifeMD's Change in Accured Expenses (Quarter) stood at $771146.0 in 2021, then increased by 28.83% to $993498.0 in 2022, then tumbled by 193.85% to -$932374.0 in 2023, then surged by 144.26% to $412706.0 in 2024, then skyrocketed by 1022.66% to $4.6 million in 2025.
  • Its Change in Accured Expenses stands at $4.6 million for Q3 2025, versus -$3.1 million for Q2 2025 and -$2.3 million for Q1 2025.